![Sphere that has the top right fourth removed (exposed) Colors from left are orange, dark blue with orange dots, light blue with horizontal lines, then black. Inside the exposure is green and black with boxes.](/sites/default/files/styles/featured_square_large/public/2024-06/slicer.jpg?h=56311bf6&itok=bCZz09pJ)
Filter News
Area of Research
News Topics
- (-) Biomedical (9)
- (-) Cybersecurity (1)
- (-) Frontier (7)
- (-) Isotopes (13)
- (-) Mercury (3)
- (-) Space Exploration (4)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (3)
- Artificial Intelligence (19)
- Big Data (3)
- Bioenergy (16)
- Biology (23)
- Biotechnology (6)
- Buildings (9)
- Chemical Sciences (7)
- Clean Water (3)
- Climate Change (10)
- Composites (2)
- Computer Science (24)
- Coronavirus (2)
- Critical Materials (1)
- Decarbonization (15)
- Education (1)
- Emergency (1)
- Energy Storage (7)
- Environment (31)
- Exascale Computing (7)
- Fossil Energy (2)
- Fusion (6)
- Grid (5)
- High-Performance Computing (17)
- ITER (1)
- Machine Learning (5)
- Materials (14)
- Materials Science (17)
- Mathematics (2)
- Microscopy (5)
- Nanotechnology (4)
- National Security (13)
- Net Zero (3)
- Neutron Science (12)
- Nuclear Energy (10)
- Partnerships (9)
- Physics (5)
- Polymers (2)
- Quantum Computing (9)
- Quantum Science (16)
- Security (4)
- Simulation (8)
- Statistics (1)
- Summit (8)
- Sustainable Energy (17)
- Transportation (9)
Media Contacts
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Technicians John Dyer and T. Dyer use a manipulator arm in a shielded cave in ORNL’s Radiochemical Engineering Development Center to separate concentrated Pm-147 from byproducts generated through the production of Pu-238.](/sites/default/files/styles/list_page_thumbnail/public/2021-03/Promethium%20feature_0.jpg?h=a1f525db&itok=6XSsJdot)
A new method developed at Oak Ridge National Laboratory proves one effort’s trash is another’s valuable isotope. One of the byproducts of the lab’s national plutonium-238 production program is promethium-147, a rare isotope used in nuclear batteries and to measure the thickness of materials.
![The Perseverance rover](/sites/default/files/styles/list_page_thumbnail/public/2020-07/pia23492_0.jpg?h=d1cb525d&itok=A5U6cgBE)
On Feb. 18, the world will be watching as NASA’s Perseverance rover makes its final descent into Jezero Crater on the surface of Mars. Mars 2020 is the first NASA mission that uses plutonium-238 produced at the Department of Energy’s Oak Ridge National Laboratory.